Treatment of the human promyelocytic leukemia cell line HL-60 with antisense oligodeoxynucleotides to UDP-N-acetylgalactosamine: 3-1,4-N-acetylgalactosaminyltransferase (GM2-synthase; EC 2.4.1.92) and CMP-sialic acid:a-2,8-sialyltransferase (GD3-synthase; EC 2.4.99.8) sequences effectively down-regulated the synthesis of more complex gangliosides in the ganglioside synthetic pathways after GM3, resulting in a remarkable increase in endogenous GM3 with concomitant decreases in more complex gangliosides. The treated cells underwent monocytic differentiation as judged by morphological clwiges, adherent ability, and nitroblue tetrazolium staining.
The composition of gangliosides -in cells undergoes dramatic changes during cellular growth, differentiation, and oncogenic transformation, suggesting a specific role of gangliosides in the regulation of these cellular events (3) (4) (5) . The human promyelocytic leukemia HL-60 cells can be induced to mature along either the monocyte/macrophage or the granulocyte pathway by exposure to different inducers of differentiation. When HL-60 cells are induced to monocytic differentiation by "phorbol 12-O-tetradecanoate 13-acetate" (TPA), the activity of CMP-N-acetylneuraminic acid:lactosylceramide sialyltransferase (GM3-synthase; EC 2.4.99.9) and the amount of its product GM3 increase (6) . Additionally, exogenously administered gangliosides are known to affect the morphological and biochemical properties of cultured cells (7) . Administration of GM3 induces HL-60 cells to monocytic differentiation (8) and enhances differentiation of oligodendrocytes cultured from developing rat brain (9) . Exogenously added GM3 promotes process formation by cultured bovine oligodendrocytes and stimulates the release of glycoproteins into the medium (10) . These results suggest that ganglioside GM3 may be involved in the cellular differentiation process, perhaps by regulating growth factor receptor activities (4, 11, 12) . It has not been demonstrated, however, that the effect of exogenously added gangliosides reflects the biological function of endogenous gangliosides.
In the ganglioside biosynthetic pathways, GM3 is a unique intermediate in that it can be further converted to GM2 in the a-series or GD3 in the b-series by the action of UDP-Nacetylgalactosamine:43-1,4-N-acetylgalactosaminyltransferase (GM2-synthase; EC 2.4.1.92) or CMP-sialic acid:a-2,8-sialyltransferase (GD3-synthase; EC 2.4.99.8), respectively ( Fig. 1) . It has been demonstrated (13) (14) (15) 21 nucleotides encoding human GM2-or GD3-synthase (16, 17) at the 5' end and including the initiator codon ATG. They were 5 '-GACAGGATGTGGCTGGGCCGC-3' (GM2-synthase sense oligodeoxynucleotide), 5'-GCGGCCCAGCCACATC-CTGTC-3' (GM2-synthase antisense oligodeoxynucleotide), 5 '-AGAGGGGCCATGGCTGTACTG-3' (GD3-synthase sense oligodeoxynucleotide), and 5'-CAGTACAGCCATG-GCCCCTCT-3' (GD3-synthase antisense oligodeoxynucleotide). Cells were grown as described above but in a 24-well culture plate to minimize consumption of oligodeoxynucleotides. In this experiment, cells were resuspended in serum-free RPMI 1640 medium containing the oligodeoxynucleotides at 30 ,uM at 37°C for 30 min and then fetal bovine serum was added to 5%. Wickstrom et al. (18) reported that 1-2% of a 15-base oligomer is taken up and this level remains about the same up to 24 h in HL-60 cells although degradation of oligodeoxynucleotides in RPMI 1640 medium with 10% fetal bovine serum is completed by 8 h. Therefore, to obtain efficient hybridization arrest, the medium containing the oligodeoxynucleotides was changed every 2 days. Ganglioside GM3 was purified from bovine adrenal medulla (19) . Treatment of HL-60 cells with GM3 was performed as described by Nojiri et al. (8) except that in some experiments RPMI 1640 medium with 5% fetal bovine serum was used to replace the synthetic medium (20) . TPA at 3-5 nM was used to induce monocytic differentiation of HL-60 cells as described (21) .
Assay of Glycosyltransferase Activities. HL-60 cells were treated with 5 nM TPA, 50 ,tM GM3, or either sense or antisense oligomers to GM2-and GD3-synthases (each oligomer at 30 ,uM) for 4 days, respectively. The activities of GM3-synthase, GM2-synthase, and GD3-synthase were determined as described (22) (23) (24) 5 .75 mCi/mmol) in 0.5 ml of medium for 24 h before harvest.
The acidic and neutral glycolipids were separated on a DEAESephadex column (25) . The individual acidic glycolipids were then resolved on a high-performance thin-layer chromatographic plate with the developing system of CHCl3/CH30H/ aqueous 0.2% CaCl2-2H20, 50:45:10 (vol/vol). The glycolipid bands containing the 14C label were visualized by exposure to an x-ray film.
Measurement of Cellular Proliferation. Cell numbers were determined by counting the trypan blue-excluding cells in a hemocytometer as described (21 30 ,uM GM2-or 30 ,iM GM3-synthase sense oligomers, 30 ,iM GM2-or 30 ,iM GD3-synthase antisense oligomers, or 30 j,M GM2-synthase antisense oligomer alone for 4 days, respectively. The activities of GM3-synthase (A), GM2-synthase (B), and GD3-synthase (C) in the treated and untreated cells were determined. The enzyme activities were expressed as percentages of the total activities from HL-60 cells cultured in the absence of differentiation-inducing agents.
Each value represents the mean ± SD of at least three determinations.
One hundred percent was equal to 1.36 ± 0.12 nmol per mg of protein per h, 3 .62 ± 0.06 nmol per mg of protein per h, and 1.73 ± 0.18 nmol per mg of protein per h for GM3-, GM2-, and GD3-synthase activities, respectively. The activity of GM2-synthase in the presence of GM2-and GD3-synthase antisense oligomers was not determined (B), nor was the activity of GM3-synthase in the presence of GM2-synthase antisense oligomer (A). matic reduction (60-80%) of the activity of GM2-and/or GD3-synthases (Fig. 2) . Sense oligodeoxynucleotides to GM2-or GD3-synthase sequences, which served as controls, failed to alter the activity of GM2-or GD3-synthase, and both the sense and the antisense oligomers had no effect on the activity of GM3-synthase. These results clearly indicated that the antisense oligodeoxynucleotides suppressed the expression of GM2-and GD3-synthases specifically and efficiently. Fig. 2 also shows that the activity of GM3-synthase increased when HL-60 cells were treated with TPA, as reported (6, 21) . The composition of HL-60-cell gangliosides after exposure to TPA, the GM2-synthase antisense oligomer alone, or a combination of GM2-and GD3-synthase antisense oligomers was studied by [14C]galactose incorporation experiments. At the end of 14C labeling, gangliosides were extracted from the cells. The 14C incorporation in gangliosides in all samples was 2700 ± 250 cpm per 106 cells (equal to 213 ± 19 pmol of radioactive galactose), indicating that the total amounts of newly synthesized gangliosides were not affected by the treatments. However, the distribution of the 14C incorporation, i.e., the ganglioside composition after the treatment with antisense oligomers or TPA, was significantly altered as analyzed by thin-layer chromatography and autoradiography (Fig. 3) . The ganglioside composition of each sample from autoradiography was then subjected to densitometry and the data obtained from three determinations were expressed as percentages, which are shown in Table 1 . Treatment of HL-60 cells with GM2-and GD3-synthase antisense oligomers resulted in an increase in the proportion of GM3, which was accompanied by a drastic decrease in the levels of GM2 and GM1. These data indicate that suppression of GM2-and GD3-synthases by the antisense oligomers could lead to the accumulation of the common substrate GM3 of the two enzymes. A remarkable accumulation of GM3 was also achieved by TPA induction, presumably by stimulation of the activities of GM3-synthase (Figs. 2 and 3 and Table 1 ). When HL-60 cells were treated with GM2-synthase antisense oligomer alone, both GM3 and GD3 increased (Fig. 3, lane 2, and Table 1 ). The increase in GD3 concentrations was even more striking than that in GM3. It has been reported that the increase in the amount of GM3 ganglioside during induced HL-60 cell differentiation can be affected by the increased amount of the metabolic precursor LacCer, which in turn may result in an increase of the activity of GM3-synthase (27) . Our results showed an increase in the activity of GD3-synthase when ganglioside synthesis in the a-series was blocked (Fig. 2) . Besides, there was no significant change in the amount of GD2 and GDlb between the treated and untreated cells, and gangliosides in the b-series were only (Fig. 3, lane 3) . The striking increase in the concentration of GD3 is most likely due to the conversion of the accumulated precursor GM3 to GD3 by the increased activity of GD3-synthase. This observation again indicates the effectiveness of employing antisense DNA technology in modulating the activity of GD3-and/or GM2-synthase and thereby achieving the goal of regulating ganglioside expression in HL-60 cells.
Previous studies from several laboratories showed that exposure of HL-60 cells to 5 nM TPA or 50 ,uM GM3 strongly inhibited cellular growth (21, 28) . In the present investigation, however, we found that addition of the GM2-and GD3-synthase antisense oligodeoxynucleotides to HL-60 cells only had a slight effect on cellular growth (ref. 24 and data not shown). Treatment of the cells with TPA for 3 days resulted in cell attachment (>90%) to the surface of the culture plate (Fig. 4 B and E) . About 10% adherent cells were found after incubation of the cells with 30 ,uM antisense oligomers for 6 days (Fig. 4 C and F) . Adherent cells were not seen in untreated HL-60 cells (Fig. 4 A and D) , cells treated with the corresponding sense oligomers, or cells treated with exogenous GM3, which was added in either a synthetic serum-free medium (20) or a medium containing 5% fetal bovine serum (data not shown). On the other hand, HL-60 cells treated with the antisense oligomers showed morphological changes characteristic of monocytic differentiation (Fig. 4 C and F exposure of HL-60 cells to TPA and the sense and the antisense oligomers to GM2-and GD3-synthases, the degree of differentiation was monitored by measuring the ability of differentiated cells to reduce soluble NBT to insoluble blueblack formazan. As shown in Fig. 5 , we found strong NBTpositive cells in the culture containing the GM2-and GD3-synthase antisense oligomers. Significant increases in NBTreducing activity were observed in cultures treated with either the oligomers or TPA as shown in Table 2 .
In conclusion, we have induced HL-60 cells to monocytic differentiation with oligodeoxynucleotides antisense to GM2-and GD3-synthase sequences as judged by morphological changes, cell attachment to the surface of culture plates, and NBT staining. These differentiation-associated changes were accompanied by an increase in the concentration of GM3 and a decrease in the concentrations of more complex ganglioseries gangliosides. Since the common feature of the cellular differentiation induced in HL-60 cells by TPA (6, 21) , exogenously added GM3 (21, 28) , or the antisense oligodeoxynucleotides, observed in the present study, is a remarkable increase in cellular GM3 concentrations, our data suggest that the increase in endogenous GM3 may be associated with the cellular differentiation process. GM3 has been shown to induce oligodendrocyte differentiation (9) . Additionally, GM3 is capable of retarding cellular growth by inhibiting epidermal growth factor-dependent receptor autophosphorylation in cultured fibroblasts (11, 12) and modulating several protein kinase systems in cultured brain microvascular endothelial cells (29) . Whereas the precise mechanism by which cell surface GM3 may trigger cellular differentiation remains to be defined (30) , our present investigation nonetheless demonstrates a strategy to control glycolipid biosynthesis that uses defined antisense DNA techniques. This strategy should prove to be a powerful tool in elucidating the functional role of glycolipids in cellular differentiation and growth. 
